Defunct Company
Total Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
543
NCT00537693
Cytokine Removal by CRRT in Pediatric Sepsis
Phase: N/A
Role: Collaborator
Start: Sep 30, 2007
Completion: May 31, 2010
NCT00794651
Osteoarthritis Bedside Testing Kit
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Jun 30, 2009
NCT01166295
Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia
Start: Jul 31, 2010
Completion: Nov 30, 2010
NCT01264237
Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain
Phase: Phase 4
Start: Mar 31, 2011
Completion: Apr 30, 2012
NCT01329406
Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis
Start: Jul 31, 2011
Completion: Sep 30, 2012
NCT01557816
Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee
Start: Dec 31, 2011
Completion: Jun 30, 2012
NCT01562353
Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction
Start: Apr 30, 2012
Completion: Dec 31, 2013
NCT01770964
Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Start: Dec 31, 2012
Completion: Jul 31, 2013
NCT02842554
"Training Pain Connoisseurs for Efficient Analgesic Proof-of-Concept Studies"
Start: Aug 31, 2013
Completion: Oct 31, 2015
NCT02702778
Delayed Release Prednisone in PMR
Phase: Phase 2
Start: Feb 29, 2016
Completion: Mar 31, 2017